Tigran Avoian, MD
Emergency Medical Services · Los Angeles, CANPI 1649402678
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Amgen at 24.6% of the total. Reporting peaked in 2022 at $163 and has fallen 84.0% since, to $26 in 2025.
Across 34 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$160
- GSK$149
- Merck$96
- Mylan Specialty L.p.$47
- Sanofi-aventis U.S. LLC$28
- La Jolla Pharmaceutical Company$28
- plus $143 from 7 others
What the payments were for
- Food & beverage$652100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 11 | $160 |
| GSK | 7 | $149 |
| Merck | 5 | $96 |
| Mylan Specialty L.p. | 2 | $47 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| La Jolla Pharmaceutical Company | 1 | $28 |
| Vertex | 1 | $26 |
| Gilead | 1 | $23 |
| Zimmer Biomet | 1 | $23 |
| Circassia Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Johnson & Johnson | 1 | $12 |
How this compares
$652 in reported general payments places this provider in the 75th percentile of 103 emergency medical services providers in California.
See all emergency medical services providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 2,204 | $1,786,284 |
| Diclofenac Potassium | 13 | $25,431 |
| Celecoxib | 942 | $15,563 |
| MeloxicamMeloxicam, Submicronized | 15 | $12,515 |
| Lidocaine | 41 | $3,907 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 282 | $1,665 |
| Methylprednisolone | 98 | $526 |
| Meloxicam | 201 | $256 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $236 |
| Ibuprofen | 34 | $107 |
| Gabapentin | 48 | $78 |
| Naproxen | 24 | $77 |
| Tramadol Hcl | 40 | $65 |
| Cyclobenzaprine Hcl | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other emergency medical services in Los Angeles
- William MowerLos Angeles$12K
- Stephanie TangLos Angeles$1K
- Lynne McCulloughLos Angeles$1K
- Gregory JahangiriLos Angeles$1K
- Louis AcostaLos Angeles$714
- Sujal MandaviaLos Angeles$652
- Heather FlahertyLos Angeles$565
- Tiffany HackettLos Angeles$205
- Stephen BauerLos Angeles$199
- Angelique CampenLos Angeles$178
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.